Tolerance of iohexol, iopamidol, and metrizamide in lumbar myelography.
Iohexol and iopamidol, two new nonionic contrast media, have been extensively studied in comparison with metrizamide for lumbar myelography. Review of the literature with statistical analysis indicates both agents are superior to metrizamide in terms of number of patients with adverse reactions (p less than 0.001). Preliminary data suggest, but do not prove, that use of iohexol may result in fewer side effects than iopamidol.
D006801:Humans; D007472:Iohexol / Q000009:adverse effects*; D007479:Iopamidol / Q000009:adverse effects*; D008793:Metrizamide / Q000009:adverse effects*; D009192:Myelography; D011446:Prospective Studies; D011897:Random Allocation
D007472:Iohexol; D007479:Iopamidol; D008793:Metrizamide